{"id":10418,"date":"2025-04-09T07:19:58","date_gmt":"2025-04-09T07:19:58","guid":{"rendered":"https:\/\/ambercell.eu\/?page_id=10418"},"modified":"2026-11-12T13:35:59","modified_gmt":"2026-11-12T11:35:59","slug":"selektiivne-arterisisene-kiiritusravi-sirt-2","status":"publish","type":"page","link":"https:\/\/ambercell.eu\/et\/arstide-jaoks\/sudame-veresoonkonna-haigused\/selektiivne-arterisisene-kiiritusravi-sirt-2\/","title":{"rendered":"Perkutaanne koronaarne sekkumine (CTO PCI)"},"content":{"rendered":"\t\t<div data-elementor-type=\"wp-page\" data-elementor-id=\"10418\" class=\"elementor elementor-10418 elementor-10416\" data-elementor-post-type=\"page\">\n\t\t\t\t<div class=\"elementor-element elementor-element-55dcfde e-flex e-con-boxed e-con e-parent\" data-id=\"55dcfde\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t<div class=\"elementor-element elementor-element-0829351 e-con-full e-flex e-con e-child\" data-id=\"0829351\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t<div class=\"elementor-element elementor-element-e9e7c1a e-flex e-con-boxed e-con e-child\" data-id=\"e9e7c1a\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t<div class=\"elementor-element elementor-element-d171ab2 e-flex e-con-boxed e-con e-child\" data-id=\"d171ab2\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-a7f68e9 elementor-widget elementor-widget-spacer\" data-id=\"a7f68e9\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"spacer.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<div class=\"elementor-spacer\">\n\t\t\t<div class=\"elementor-spacer-inner\"><\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-a52c32b elementor-widget elementor-widget-text-editor\" data-id=\"a52c32b\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p class=\"\" data-start=\"79\" data-end=\"1198\">Krooniline t\u00e4ielik ummistus (ingl. <strong data-start=\"111\" data-end=\"138\">Krooniline t\u00e4ielik ummistus<\/strong>, CTO on \u00fcks keerukamaid ja kliiniliselt olulisemaid koronaarse sekkumise valdkondi. CTO tekib siis, kui koronaararterite s\u00fcsteem on v\u00e4hemalt kolm kuud t\u00e4ielikult ummistunud ja veri ei j\u00f5ua kahjustatud s\u00fcdameossa. Verevoolu h\u00e4irimise t\u00f5ttu ei saa s\u00fcda piisavalt hapnikku ja toitaineid, mis p\u00f5hjustab stenokardia rinna s\u00fcmptomeid. CTO esineb kuni 30% koronaararterite haigusega patsientidest <strong>[1].<\/strong> CTO juhtumeid on pikka aega peetud tehniliselt keerukate ja raskesti ravitavate invasiivsete meetoditena, kuid viimastel aastatel on perkutaansete meetodite ja spetsiaalsete seadmete areng parandanud selle seisundi ravitulemusi. CTO perkutaanse koronaarse sekkumisega (PCI) seotud protseduurilised riskid kogenud keskustes v\u00e4henevad pidevalt <strong>[0].<\/strong> Viimased edusammud intervjuukardioloogias ja uued CTO ravistrateegiad v\u00f5imaldavad suurep\u00e4raseid tulemusi, parandades patsiendi elluj\u00e4\u00e4mist ja elukvaliteeti. USA CTO ravikeskuste viimased andmed n\u00e4itavad, et CTO PCI tehnilise edukuse m\u00e4\u00e4rad \u00fcletavad 90% <strong>[20]<\/strong>.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-039908a elementor-widget elementor-widget-image\" data-id=\"039908a\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"image.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t\t\t\t<figure class=\"wp-caption\">\n\t\t\t\t\t\t\t\t\t\t<img fetchpriority=\"high\" decoding=\"async\" width=\"800\" height=\"529\" src=\"https:\/\/ambercell.eu\/wp-content\/uploads\/2025\/04\/The-components-of-chronic-total-occlusion-CTO-lesions-1.webp\" class=\"attachment-large size-large wp-image-10584\" alt=\"\" srcset=\"https:\/\/ambercell.eu\/wp-content\/uploads\/2025\/04\/The-components-of-chronic-total-occlusion-CTO-lesions-1.webp 893w, https:\/\/ambercell.eu\/wp-content\/uploads\/2025\/04\/The-components-of-chronic-total-occlusion-CTO-lesions-1-300x198.webp 300w, https:\/\/ambercell.eu\/wp-content\/uploads\/2025\/04\/The-components-of-chronic-total-occlusion-CTO-lesions-1-768x507.webp 768w\" sizes=\"(max-width: 800px) 100vw, 800px\" \/>\t\t\t\t\t\t\t\t\t\t\t<figcaption class=\"widget-image-caption wp-caption-text\">CTO laokomponendid [30]<\/figcaption>\n\t\t\t\t\t\t\t\t\t\t<\/figure>\n\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-46fae75f e-flex e-con-boxed e-con e-parent\" data-id=\"46fae75f\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t<div class=\"elementor-element elementor-element-5a746995 e-con-full e-flex e-con e-child\" data-id=\"5a746995\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t<div class=\"elementor-element elementor-element-4c9d82fd elementor-widget-divider--view-line elementor-widget elementor-widget-divider\" data-id=\"4c9d82fd\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"divider.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<div class=\"elementor-divider\">\n\t\t\t<span class=\"elementor-divider-separator\">\n\t\t\t\t\t\t<\/span>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-739014d e-flex e-con-boxed e-con e-child\" data-id=\"739014d\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t<div class=\"elementor-element elementor-element-2dff45c8 elementor-hidden-mobile e-flex e-con-boxed e-con e-child\" data-id=\"2dff45c8\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-72aae63c elementor-widget elementor-widget-heading\" data-id=\"72aae63c\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\">Mis on PCI CTO?<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-106d61f7 e-flex e-con-boxed e-con e-child\" data-id=\"106d61f7\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-396b6b44 elementor-widget elementor-widget-text-editor\" data-id=\"396b6b44\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p>Pikka aega vajasid CTO seisunditega patsiendid, kellel on stenokardia (rindkerevalu, \u00f5hupuudus, v\u00e4simus), avatud s\u00fcdameoperatsiooni \u2013 koronaararteri \u0161unteerimisoperatsiooni (CABG). T\u00e4nap\u00e4eval saab CTO-d ravida minimaalselt invasiivse meetodiga, mida nimetatakse <strong>perkutaanseks koronaarinterventsiooniks (PCI).<\/strong> See protseduur h\u00f5lmab arteri avamist \u00f5hupallide, stentide ja spetsiaalsete seadmetega. CTO PCI meetodite, seadmete ja protseduurikogemuse suurenemisega peetakse CTO PCI-d n\u00fc\u00fcd ennustatavaks ja t\u00f5husaks ravimeetodiks. Euroopa arstide juhised m\u00fcokardi veresoonte revaskulariseerimise kohta soovitavad teha CTO PCI, et v\u00e4hendada isheemiat m\u00f5jutatud m\u00fcokardipiirkonnas ja leevendada stenokardi <strong>s\u00fcmptomeid [2].<\/strong><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-58aba326 elementor-widget-divider--view-line elementor-widget elementor-widget-divider\" data-id=\"58aba326\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"divider.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<div class=\"elementor-divider\">\n\t\t\t<span class=\"elementor-divider-separator\">\n\t\t\t\t\t\t<\/span>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-8122074 e-flex e-con-boxed e-con e-parent\" data-id=\"8122074\" data-element_type=\"container\" data-e-type=\"container\" data-settings=\"{&quot;background_background&quot;:&quot;classic&quot;}\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t<div class=\"elementor-element elementor-element-5bc5ab0 e-con-full e-flex e-con e-child\" data-id=\"5bc5ab0\" data-element_type=\"container\" data-e-type=\"container\" data-settings=\"{&quot;background_background&quot;:&quot;classic&quot;}\">\n\t\t\t\t<div class=\"elementor-element elementor-element-2952f5e elementor-widget elementor-widget-heading\" data-id=\"2952f5e\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\">Patsiendi valik<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-fb2d651 elementor-widget elementor-widget-text-editor\" data-id=\"fb2d651\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p class=\"\" data-start=\"0\" data-end=\"219\">Kasutades kaasaegseid meetodeid ja seadmeid, peaks patsiendi valik p\u00f5hinema mitte ainult kahjustuse taseme (t\u00e4ielik, osaline v\u00f5i raske) m\u00e4\u00e4ramisel, vaid ka s\u00fcmptomitel ja diagnostilistel <strong>tulemustel [3].<\/strong><\/p>\n<p class=\"\" data-start=\"221\" data-end=\"302\">Praegu eristavad ekspertide konsensuse alusel neli peamist CTO PCI n\u00e4idustust:<\/p>\n<ul data-start=\"304\" data-end=\"734\" data-is-last-node=\"\" data-is-only-node=\"\">\n<li class=\"\" data-start=\"304\" data-end=\"401\">\n<p class=\"\" data-start=\"306\" data-end=\"401\">S\u00fcmptomite leevendamine, mis piiravad elukvaliteeti, ja f\u00fc\u00fcsilise treeningu taluvuse paranemine.<\/p>\n<\/li>\n<li class=\"\" data-start=\"402\" data-end=\"469\">\n<p class=\"\" data-start=\"404\" data-end=\"469\">Isheemilise koormuse v\u00e4hendamine mitteinvasiivsete testide abil.<\/p>\n<\/li>\n<li class=\"\" data-start=\"470\" data-end=\"583\">\n<p class=\"\" data-start=\"472\" data-end=\"583\">Vasaku vatsakese (LV) d\u00fcsfunktsiooniga seotud hingelduse v\u00e4henemine eluj\u00f5ulise m\u00fcokardi t\u00f5endite olemasolul.<\/p>\n<\/li>\n<li class=\"\" data-start=\"584\" data-end=\"734\">\n<p class=\"\" data-start=\"586\" data-end=\"734\">Pikaajalise prognoosi paranemine k\u00f5rge riskiga mitmekordse veresoonkonna koronaararteri haigusega <strong>patsientidel [23][24][25][26][27].<\/strong><\/p>\n<\/li>\n<\/ul>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-8abc811 elementor-widget elementor-widget-text-editor\" data-id=\"8abc811\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<article class=\"text-token-text-primary w-full\" dir=\"auto\" data-testid=\"conversation-turn-12\" data-scroll-anchor=\"true\">\n<div class=\"text-base my-auto mx-auto py-5 [--thread-content-margin:--spacing(4)] @[37rem]:[--thread-content-margin:--spacing(6)] @[70rem]:[--thread-content-margin:--spacing(12)] px-(--thread-content-margin)\">\n<div class=\"[--thread-content-max-width:32rem] @[34rem]:[--thread-content-max-width:40rem] @[64rem]:[--thread-content-max-width:48rem] mx-auto flex max-w-(--thread-content-max-width) flex-1 text-base gap-4 md:gap-5 lg:gap-6 group\/turn-messages focus-visible:outline-hidden\" tabindex=\"-1\">\n<div class=\"group\/conversation-turn relative flex w-full min-w-0 flex-col agent-turn\">\n<div class=\"relative flex-col gap-1 md:gap-3\">\n<div class=\"flex max-w-full flex-col grow\">\n<div class=\"min-h-8 text-message relative flex w-full flex-col items-end gap-2 text-start break-words whitespace-normal [.text-message+&amp;]:mt-5\" dir=\"auto\" data-message-author-role=\"assistant\" data-message-id=\"bca3f07c-3a98-4f6f-a39c-4f32418db4e0\" data-message-model-slug=\"gpt-4o\">\n<div class=\"flex w-full flex-col gap-1 empty:hidden first:pt-[3px]\">\n<div class=\"markdown prose dark:prose-invert w-full break-words light\">\n<p class=\"\" data-start=\"0\" data-end=\"380\">CTO on sagedasem eakatel patsientidel. Uuringud n\u00e4itavad, et CTO levimus on 36,5% alla 65-aastaste patsientide seas, 39,1% vanuses 65\u201379 ja 40,7% \u00fcle 80-aastaste<strong> patsientide seas [16].<\/strong> K\u00f5ige sagedamini m\u00f5jutatud veresooned on parem koronaararter, millele j\u00e4rgneb vasak eesmine laskuv arter ja vasak p\u00f6\u00f6rlev arter.<\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/article>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-d1a9f63 elementor-widget elementor-widget-image\" data-id=\"d1a9f63\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"image.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t\t\t\t<figure class=\"wp-caption\">\n\t\t\t\t\t\t\t\t\t\t<img decoding=\"async\" width=\"486\" height=\"484\" src=\"https:\/\/ambercell.eu\/wp-content\/uploads\/2025\/04\/fcvm-11-1350549-g001-1.jpg\" class=\"attachment-large size-large wp-image-10588\" alt=\"\" srcset=\"https:\/\/ambercell.eu\/wp-content\/uploads\/2025\/04\/fcvm-11-1350549-g001-1.jpg 486w, https:\/\/ambercell.eu\/wp-content\/uploads\/2025\/04\/fcvm-11-1350549-g001-1-300x300.jpg 300w, https:\/\/ambercell.eu\/wp-content\/uploads\/2025\/04\/fcvm-11-1350549-g001-1-150x150.jpg 150w\" sizes=\"(max-width: 486px) 100vw, 486px\" \/>\t\t\t\t\t\t\t\t\t\t\t<figcaption class=\"widget-image-caption wp-caption-text\">CTO PCI n\u00e4idustused [29]<\/figcaption>\n\t\t\t\t\t\t\t\t\t\t<\/figure>\n\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-d25e8dd elementor-widget elementor-widget-text-editor\" data-id=\"d25e8dd\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p>As\u00fcmptomaatiliste patsientide puhul tuleks isheemiat enne CTO-d hinnata PCI poolt. Protseduuri edukus s\u00f5ltub sellest, kas s\u00fcdamekude suudab siiski taastuda. Soovitatav on kasutada p\u00f5hjalikke diagnostilisi meetodeid, nagu transmuraalse infarkti hindamine, kontraktilise reservi hindamine dobutamiiniga ja s\u00fcdame MRI, et hinnata normaalset m\u00fcokardi seina paksenemise funktsiooni<strong> [5].<\/strong><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-20b82f8 e-flex e-con-boxed e-con e-parent\" data-id=\"20b82f8\" data-element_type=\"container\" data-e-type=\"container\" data-settings=\"{&quot;background_background&quot;:&quot;classic&quot;}\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t<div class=\"elementor-element elementor-element-aeef9e4 e-con-full e-flex e-con e-child\" data-id=\"aeef9e4\" data-element_type=\"container\" data-e-type=\"container\" data-settings=\"{&quot;background_background&quot;:&quot;classic&quot;}\">\n\t\t\t\t<div class=\"elementor-element elementor-element-2e56834 elementor-widget elementor-widget-heading\" data-id=\"2e56834\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\">Protseduuride planeerimine<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-7d0fe7f elementor-widget elementor-widget-text-editor\" data-id=\"7d0fe7f\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<article class=\"text-token-text-primary w-full\" dir=\"auto\" data-testid=\"conversation-turn-18\" data-scroll-anchor=\"true\">\n<div class=\"text-base my-auto mx-auto py-5 [--thread-content-margin:--spacing(4)] @[37rem]:[--thread-content-margin:--spacing(6)] @[70rem]:[--thread-content-margin:--spacing(12)] px-(--thread-content-margin)\">\n<div class=\"[--thread-content-max-width:32rem] @[34rem]:[--thread-content-max-width:40rem] @[64rem]:[--thread-content-max-width:48rem] mx-auto flex max-w-(--thread-content-max-width) flex-1 text-base gap-4 md:gap-5 lg:gap-6 group\/turn-messages focus-visible:outline-hidden\" tabindex=\"-1\">\n<div class=\"group\/conversation-turn relative flex w-full min-w-0 flex-col agent-turn\">\n<div class=\"relative flex-col gap-1 md:gap-3\">\n<div class=\"flex max-w-full flex-col grow\">\n<div class=\"min-h-8 text-message relative flex w-full flex-col items-end gap-2 text-start break-words whitespace-normal [.text-message+&amp;]:mt-5\" dir=\"auto\" data-message-author-role=\"assistant\" data-message-id=\"1e85cd96-aaac-4115-90e5-abef1d3e770b\" data-message-model-slug=\"gpt-4o\">\n<div class=\"flex w-full flex-col gap-1 empty:hidden first:pt-[3px]\">\n<div class=\"markdown prose dark:prose-invert w-full break-words light\">\n<p class=\"\" data-start=\"0\" data-end=\"431\">Eelprotseduuriline planeerimine h\u00f5lmab angiograafilist hindamist, et hinnata edu t\u00f5en\u00e4osust ja valida sobivaim sekkumismeetod. \u00dcks enim kasutatavaid t\u00f6\u00f6riistu on <em>J-CTO<\/em> skoor. H\u00fcbriidalgoritm parandab edukuse m\u00e4\u00e4ra, v\u00e4hendades protseduuri kestust, kiirgusdoosi ja kontrastaine kogust, samuti standardiseerides metoodikaid ja v\u00e4hendades erinevusi <strong>operaatorit\u00f6\u00f6s [11][12].<\/strong><\/p>\n<p class=\"\" data-start=\"433\" data-end=\"1247\">Standardiseeritud h\u00fcbriidalgoritmi abil saavutavad raviasutused P\u00f5hja-Ameerikas ja Euroopas \u00fcle 90% edukuse m\u00e4\u00e4ra. See meetod h\u00f5lmab kahe juhtiva kateetri paigaldamist \u2013 \u00fcks kummasse koronaararterisse \u2013 et teha topeltkontrasti s\u00fcst ja tagada sujuv \u00fcleminek antegrad- ja retrograadse juhtivuse meetodi vahel. Topeltkontrastiga angiogramm v\u00f5imaldab hinnata kahjustuse omadusi, nagu kollateraalvereringe pikkus ja anatoomia. Nende andmete p\u00f5hjal valivad arstid protseduuri ajal optimaalse juhendamismeetodi ning j\u00e4lgivad protseduuri parameetreid \u2013 kestus, kiiritus ja kontrastaine kogus. See algoritm t\u00f6\u00f6tab isegi k\u00f5rge riskiga patsientide puhul, kes on l\u00e4binud CABG operatsiooni \u2013 saavutades 87,5% edukuse m\u00e4\u00e4ra<strong> [11].<\/strong><\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/article>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-f159a4d e-flex e-con-boxed e-con e-parent\" data-id=\"f159a4d\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t<div class=\"elementor-element elementor-element-0ca71ba e-flex e-con-boxed e-con e-child\" data-id=\"0ca71ba\" data-element_type=\"container\" data-e-type=\"container\" data-settings=\"{&quot;background_background&quot;:&quot;classic&quot;}\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t<div class=\"elementor-element elementor-element-0ba41a7 e-con-full e-flex e-con e-child\" data-id=\"0ba41a7\" data-element_type=\"container\" data-e-type=\"container\" data-settings=\"{&quot;background_background&quot;:&quot;classic&quot;}\">\n\t\t\t\t<div class=\"elementor-element elementor-element-6307d0c elementor-widget elementor-widget-heading\" data-id=\"6307d0c\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\">CTO protseduuri etapid<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-9e976be elementor-widget elementor-widget-text-editor\" data-id=\"9e976be\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<article class=\"text-token-text-primary w-full\" dir=\"auto\" data-testid=\"conversation-turn-20\" data-scroll-anchor=\"true\">\n<div class=\"text-base my-auto mx-auto py-5 [--thread-content-margin:--spacing(4)] @[37rem]:[--thread-content-margin:--spacing(6)] @[70rem]:[--thread-content-margin:--spacing(12)] px-(--thread-content-margin)\">\n<div class=\"[--thread-content-max-width:32rem] @[34rem]:[--thread-content-max-width:40rem] @[64rem]:[--thread-content-max-width:48rem] mx-auto flex max-w-(--thread-content-max-width) flex-1 text-base gap-4 md:gap-5 lg:gap-6 group\/turn-messages focus-visible:outline-hidden\" tabindex=\"-1\">\n<div class=\"group\/conversation-turn relative flex w-full min-w-0 flex-col agent-turn\">\n<div class=\"relative flex-col gap-1 md:gap-3\">\n<div class=\"flex max-w-full flex-col grow\">\n<div class=\"min-h-8 text-message relative flex w-full flex-col items-end gap-2 text-start break-words whitespace-normal [.text-message+&amp;]:mt-5\" dir=\"auto\" data-message-author-role=\"assistant\" data-message-id=\"252eebdb-b10f-4779-aad3-129f7747e992\" data-message-model-slug=\"gpt-4o\">\n<div class=\"flex w-full flex-col gap-1 empty:hidden first:pt-[3px]\">\n<div class=\"markdown prose dark:prose-invert w-full break-words light\">\n<p class=\"\" data-start=\"0\" data-end=\"225\">Protseduur sarnaneb s\u00fcdame kateteriseerimisele. Selge kliinilise n\u00e4idustuse p\u00f5hjendamiseks peab patsient enne protseduuri l\u00e4bima p\u00f5hjaliku l\u00e4bivaatuse, sealhulgas s\u00fcmptomite, isheemia ja m\u00fcokardi eluj\u00f5ulisuse<strong> hindamise [9].<\/strong><\/p>\n<p class=\"\" data-start=\"227\" data-end=\"258\">Protseduuri peamised etapid:<\/p>\n<ul data-start=\"260\" data-end=\"779\" data-is-last-node=\"\" data-is-only-node=\"\">\n<li class=\"\" data-start=\"260\" data-end=\"354\">\n<p class=\"\" data-start=\"262\" data-end=\"354\"><strong data-start=\"262\" data-end=\"292\">Juhitud kateetri paigaldamine<\/strong> \u2013 v\u00f5imaldab ligip\u00e4\u00e4su CTO (kroonilise t\u00e4ieliku ummistuse) kohale.<\/p>\n<\/li>\n <li class=\"\" data-start=\"355\" data-end=\"446\">\n<p class=\"\" data-start=\"357\" data-end=\"446\"><strong data-start=\"357\" data-end=\"385\">Juhttraadi \u00fclekanne<\/strong> \u2013 kasutatakse spetsiaalseid CTO juhtmeid ja mikrokateetreid.<\/p>\n<\/li>\n <li class=\"\" data-start=\"447\" data-end=\"591\">\n<p class=\"\" data-start=\"449\" data-end=\"591\"><strong data-start=\"449\" data-end=\"496\">Disektsiooni ja uuesti sisenemise tehnikad<\/strong> \u2013 keerulistel juhtudel saab rakendada retrograadset meetodit l\u00e4bi kolteraalarterite.<\/p>\n<\/li>\n<li class=\"\" data-start=\"592\" data-end=\"682\">\n<p class=\"\" data-start=\"594\" data-end=\"682\"><strong data-start=\"594\" data-end=\"621\">Balloon-angioplastika<\/strong> \u2013 kui juhttraat on edukalt paigaldatud, laiendatakse arter.<\/p>\n<\/li>\n <li class=\"\" data-start=\"683\" data-end=\"779\">\n<p class=\"\" data-start=\"685\" data-end=\"779\"><strong data-start=\"685\" data-end=\"700\">Stentimine<\/strong> \u2013 veresoonte l\u00e4bipaistevuse tagamiseks ja restenoosi riski v\u00e4hendamiseks.<\/p>\n<\/li>\n<\/ul>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/article>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-cd714c6 elementor-widget elementor-widget-heading\" data-id=\"cd714c6\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\">CTO PCI tehnika<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-795a6b3 elementor-widget elementor-widget-text-editor\" data-id=\"795a6b3\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<article class=\"text-token-text-primary w-full\" dir=\"auto\" data-testid=\"conversation-turn-22\" data-scroll-anchor=\"true\">\n<div class=\"text-base my-auto mx-auto py-5 [--thread-content-margin:--spacing(4)] @[37rem]:[--thread-content-margin:--spacing(6)] @[70rem]:[--thread-content-margin:--spacing(12)] px-(--thread-content-margin)\">\n<div class=\"[--thread-content-max-width:32rem] @[34rem]:[--thread-content-max-width:40rem] @[64rem]:[--thread-content-max-width:48rem] mx-auto flex max-w-(--thread-content-max-width) flex-1 text-base gap-4 md:gap-5 lg:gap-6 group\/turn-messages focus-visible:outline-hidden\" tabindex=\"-1\">\n<div class=\"group\/conversation-turn relative flex w-full min-w-0 flex-col agent-turn\">\n<div class=\"relative flex-col gap-1 md:gap-3\">\n<div class=\"flex max-w-full flex-col grow\">\n<div class=\"min-h-8 text-message relative flex w-full flex-col items-end gap-2 text-start break-words whitespace-normal [.text-message+&amp;]:mt-5\" dir=\"auto\" data-message-author-role=\"assistant\" data-message-id=\"fc5c261e-2ef9-44f9-8836-823ebea78ecb\" data-message-model-slug=\"gpt-4o\">\n<div class=\"flex w-full flex-col gap-1 empty:hidden first:pt-[3px]\">\n<div class=\"markdown prose dark:prose-invert w-full break-words light\">\n<p class=\"\" data-start=\"0\" data-end=\"176\">CTO PCI n\u00f5uab tehnilisi oskusi ja spetsiaalset varustust. Peamised tehnikad h\u00f5lmavad:<\/p>\n<ul data-start=\"178\" data-end=\"675\">\n<li class=\"\" data-start=\"178\" data-end=\"308\">\n<p class=\"\" data-start=\"180\" data-end=\"308\"><strong data-start=\"180\" data-end=\"228\">Antegrade juhttraadi eskaleerimine (AWE):<\/strong> \u00fcha j\u00e4igemaid juhttraate kasutatakse okklusiooni l\u00e4bistamiseks.<\/p>\n<\/li>\n<li class=\"\" data-start=\"309\" data-end=\"447\">\n<p class=\"\" data-start=\"311\" data-end=\"447\"><strong data-start=\"311\" data-end=\"366\">Antegradne dissektsioon ja taassisenemine (ADR):<\/strong> l\u00e4biviiakse kontrollitud subintiimne dissektsioon kahjustuse \u00fcletamiseks.<\/p>\n<\/li>\n<li class=\"\" data-start=\"448\" data-end=\"589\">\n<p class=\"\" data-start=\"450\" data-end=\"589\"><strong data-start=\"450\" data-end=\"475\">Retrogradne meetod<\/strong>: kahjustusele p\u00e4\u00e4setakse l\u00e4bi kolteraalarterite, mida tavaliselt rakendatakse juhul, kui eeluuringud eba\u00f5nnestuvad.<\/p>\n<\/li>\n<li class=\"\" data-start=\"590\" data-end=\"675\">\n<p class=\"\" data-start=\"592\" data-end=\"675\"><strong data-start=\"592\" data-end=\"614\">H\u00fcbriidmeetod<\/strong>: \u00fchendab mitu strateegiat parimate tulemuste saavutamiseks.<\/p>\n<\/li>\n<\/ul>\n<p class=\"\" data-start=\"677\" data-end=\"966\">Hiljutised uuringud n\u00e4itavad, et h\u00fcbriidl\u00e4henemine saavutab 85\u201390% <strong>edu [6][7][8]<\/strong> ja \u00fcle <strong>90%<\/strong> tehnilise edu USA CTO keskustes. Rangelt h\u00fcbriidl\u00e4henemist j\u00e4rgides ulatuvad edukuse m\u00e4\u00e4rad 93,4%-ni patsientidel, kellel pole eelnevat CABG operatsiooni, ja 88,1% p\u00e4rast CABG-d<strong> [20].<\/strong><\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/article>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-61ad97d elementor-widget elementor-widget-image\" data-id=\"61ad97d\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"image.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<img decoding=\"async\" width=\"844\" height=\"743\" src=\"https:\/\/ambercell.eu\/wp-content\/uploads\/2025\/04\/technikos.jpg\" class=\"attachment-full size-full wp-image-10597\" alt=\"\" srcset=\"https:\/\/ambercell.eu\/wp-content\/uploads\/2025\/04\/technikos.jpg 844w, https:\/\/ambercell.eu\/wp-content\/uploads\/2025\/04\/technikos-300x264.jpg 300w, https:\/\/ambercell.eu\/wp-content\/uploads\/2025\/04\/technikos-768x676.jpg 768w\" sizes=\"(max-width: 844px) 100vw, 844px\" \/>\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-67f95df e-flex e-con-boxed e-con e-parent\" data-id=\"67f95df\" data-element_type=\"container\" data-e-type=\"container\" data-settings=\"{&quot;background_background&quot;:&quot;classic&quot;}\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t<div class=\"elementor-element elementor-element-d91a867 e-con-full e-flex e-con e-child\" data-id=\"d91a867\" data-element_type=\"container\" data-e-type=\"container\" data-settings=\"{&quot;background_background&quot;:&quot;classic&quot;}\">\n\t\t\t\t<div class=\"elementor-element elementor-element-c484acf elementor-widget elementor-widget-heading\" data-id=\"c484acf\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\">CTO PCI eelised<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-19853e0 elementor-widget elementor-widget-text-editor\" data-id=\"19853e0\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p>CTO PCI on kiiresti arenev valdkond. Sobiva varustuse ja kaasaegsete tehnikate abil saavutavad suured ja k\u00f5rgelt p\u00e4devad keskused k\u00f5rgeid edukuse m\u00e4\u00e4rasid. Edukas CTO rekanaliseerimine on seotud stenokardia intensiivsuse v\u00e4henemise, elukvaliteedi paranemise, suurenenud f\u00fc\u00fcsilise v\u00f5imekuse, vatsakeste funktsiooni ja suremuse v\u00e4henemisega.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-fdaa572 elementor-widget elementor-widget-image\" data-id=\"fdaa572\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"image.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"800\" height=\"359\" src=\"https:\/\/ambercell.eu\/wp-content\/uploads\/2025\/04\/lentele.webp\" class=\"attachment-large size-large wp-image-10601\" alt=\"\" \/>\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-2ae3393 elementor-widget elementor-widget-image\" data-id=\"2ae3393\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"image.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t\t\t\t<figure class=\"wp-caption\">\n\t\t\t\t\t\t\t\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"800\" height=\"217\" src=\"https:\/\/ambercell.eu\/wp-content\/uploads\/2025\/04\/studija-succes-rates-1024x278.jpg\" class=\"attachment-large size-large wp-image-10605\" alt=\"\" srcset=\"https:\/\/ambercell.eu\/wp-content\/uploads\/2025\/04\/studija-succes-rates-1024x278.jpg 1024w, https:\/\/ambercell.eu\/wp-content\/uploads\/2025\/04\/studija-succes-rates-300x81.jpg 300w, https:\/\/ambercell.eu\/wp-content\/uploads\/2025\/04\/studija-succes-rates-768x208.jpg 768w, https:\/\/ambercell.eu\/wp-content\/uploads\/2025\/04\/studija-succes-rates.jpg 1040w\" sizes=\"(max-width: 800px) 100vw, 800px\" \/>\t\t\t\t\t\t\t\t\t\t\t<figcaption class=\"widget-image-caption wp-caption-text\">Tehnoloogiajuhtide \u00fchishuviprojektide edukuse m\u00e4\u00e4r v\u00e4ljaannete kaupa [26] <\/figcaption>\n\t\t\t\t\t\t\t\t\t\t<\/figure>\n\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-4798d76 elementor-widget elementor-widget-text-editor\" data-id=\"4798d76\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<ul>\n<li data-start=\"83\" data-end=\"545\"><strong data-start=\"83\" data-end=\"109\">Itaalia CTO register<\/strong> hindas 1 777 patsiendi kliinilisi tulemusi ja n\u00e4itas madalamat suremust (1,4%, 4,7% ja 6,3%, lk &lt; 0,001) ning MACE esinemissagedust p\u00e4rast \u00fchte aastat (2,6%, 8,2% ja 6,9%, lk &lt; 0,001) PCI-ga ravitud patsientidel v\u00f5rreldes konservatiivse v\u00f5i kirurgilise ravi patsientidega. Selles uuringus koges optimeeritud ravimeid saanud patsientide grupp k\u00f5rgemat MACE, suremust ja uuesti hospitaliseerimisi <strong>[13].<\/strong><\/li>\n<li data-start=\"83\" data-end=\"545\"><strong data-start=\"547\" data-end=\"566\">Sapontis jt.<\/strong> hindasid 1 000 OCT PCI l\u00e4binud patsiendi elukvaliteeti. P\u00e4rast kuu pikkust j\u00e4lgimist t\u00e4heldati olulisi paranemisi k\u00f5igis <strong data-start=\"692\" data-end=\"737\">Seattle&#8217;i stenokardia skoorides (SAQ),<\/strong> <strong data-start=\"739\" data-end=\"762\">Rose&#8217;i hingeldusskaalas<\/strong> ja <strong data-start=\"766\" data-end=\"775\">PHQ-8<\/strong> <strong>piirkondades [14].<\/strong><\/li>\n<li data-start=\"83\" data-end=\"545\"><strong data-start=\"802\" data-end=\"816\">Jaapanis<\/strong> tehti aastatel 2002\u20132008 904 j\u00e4rjestikust PCI protseduuri CTO jaoks (Rathore jt, 2009). Tehniline edu saavutati 87,5% juhtudest ja protseduuriline edukus (tehniline edu ilma MACE-ta) 86,2%. Erinevate juhtide marsruutimistehnikate kasutamine kasvas igal aastal (paralleelsed juhid, retrograadne marsruutimis, intravaskulaarne ultraheli, CART meetod). Haiglas oli MACE esinemissagedus edukas CTO PCI patsientidel 1,5% ja eba\u00f5nnestunud protseduurir\u00fchmas veidi k\u00f5rgem \u2013 4,4% (p = 0,027) <strong>[21].<\/strong><\/li>\n<li data-start=\"83\" data-end=\"545\"><strong data-start=\"1349\" data-end=\"1378\">Viimane meta-anal\u00fc\u00fcs<\/strong>, mis h\u00f5lmas 9 uuringut ja \u00fcle 6400 patsiendi, v\u00f5rdles pikaajalisi kliinilisi tulemusi patsientide vahel, kellel oli edukas CTO rekanalisatsioon, ja nende vahel, kellel seda ei \u00f5nnestunud. Selle uuringu kohaselt oli edukas rekanalisatsioonis surma, MI ja MACE risk <strong data-start=\"1656\" data-end=\"1672\">ligikaudu 50% madalam<\/strong> ning <strong data-start=\"1676\" data-end=\"1735\">m\u00fcokardi revaskulariseerumise m\u00e4\u00e4r kuni 90% madalam<\/strong> <strong>[15].<\/strong><\/li>\n<li data-start=\"83\" data-end=\"545\"><strong data-start=\"1743\" data-end=\"1778\">EuroCTO multikeskuse uuring<\/strong> (&#8220;Randomiseeritud mitmekeskne uuring, mis hindab revaskulariseerimise v\u00f5i optimaalse ravi rakendamist krooniliste krooniliste koronaararterite ummistuste juhtumite korral&#8221;) m\u00e4\u00e4ras juhuslikult 396 patsienti kas CTO-PCI v\u00f5i optimaalse raviravi (OMT) gruppidesse. P\u00e4rast 12 kuud n\u00e4itas CTO-PCI r\u00fchm suuremat stenokardia sageduse v\u00e4henemist (alamskaala muutuste erinevus \u2013 5,23; 95% CI: 1,75\u20138,71; p = 0,003) ja elukvaliteedi paranemist (alamskaala muutuste erinevus \u2013 6,62; 95% CI: 1,78\u201311,46; p = 0,007), mida hinnati <strong data-start=\"2434\" data-end=\"2473\">Seattle&#8217;i stenokardia<\/strong> <strong>k\u00fcsimustiku alusel [22].<\/strong> Eduka CTO PCI-ga patsientidel esinesid v\u00e4hem f\u00fc\u00fcsilisi piiranguid, v\u00e4hem stenokardia s\u00fcmptomeid, paremat liikuvust ja suurenenud f\u00fc\u00fcsiline aktiivsus v\u00f5rreldes ainult OMT-ga ravitud patsientidega. Protseduuride ajal registreeriti ka madal t\u00fcsistuste risk ning <strong data-start=\"2733\" data-end=\"2796\">12-kuuline MACE m\u00e4\u00e4r oli sarnane OMT r\u00fchmaga<\/strong> <strong>[28].<\/strong><\/li>\n<\/ul>\n<p><strong><strong>  <\/strong><\/strong><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-7eae72e elementor-widget elementor-widget-heading\" data-id=\"7eae72e\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\">CTO PCI edukuse m\u00e4\u00e4rad ja prognoos<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-3fa96f6 elementor-widget elementor-widget-text-editor\" data-id=\"3fa96f6\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<ul>\n<li>\n<p class=\"\" data-start=\"52\" data-end=\"347\">CTO-PCI protseduuride<strong data-start=\"52\" data-end=\"111\"> edukuse m\u00e4\u00e4rad <\/strong>m\u00e4\u00e4ravad t\u00e4iustatud t\u00f6\u00f6riistad, arenenumad mikrokateetrid ja arenenud pildistamistehnoloogiad. Praegu \u00fcletavad spetsialiseeritud keskustes, kus t\u00f6\u00f6tavad kogenud protseduuride operaatorid, edukuse m\u00e4\u00e4r 85\u201390%. Protseduuride edu m\u00e4\u00e4ravad mitmed peamised tegurid:<\/p>\n<ul data-start=\"349\" data-end=\"821\">\n<li class=\"\" data-start=\"349\" data-end=\"467\">\n<p class=\"\" data-start=\"351\" data-end=\"467\"><strong data-start=\"351\" data-end=\"371\">Patsiendi valik<\/strong>: Soodne anatoomia ja h\u00e4sti arenenud k\u00f5rvalvereringev\u00f5rk parandavad tulemusi.<\/p>\n<\/li>\n <li class=\"\" data-start=\"468\" data-end=\"609\">\n<p class=\"\" data-start=\"470\" data-end=\"609\"><strong data-start=\"470\" data-end=\"495\">Arstikogemus<\/strong>: Kogenud interventsioonispetsialistid, kes kasutavad arenenud tehnikaid, suudavad keerulisi juhtumeid t\u00f5husamalt hallata.<\/p>\n<\/li>\n <li class=\"\" data-start=\"610\" data-end=\"821\">\n<p class=\"\" data-start=\"612\" data-end=\"821\"><strong data-start=\"612\" data-end=\"646\">T\u00e4iustatud pildistamistoetus<\/strong>: Tehnoloogiad nagu intravaskulaarne ultraheli (IVUS) ja optiline koherentsustomograafia (OCT) aitavad optimeerida stendi asendit ja suunata seda erakordse t\u00e4psusega.<\/p>\n<\/li>\n<\/ul>\n<p class=\"\" data-start=\"823\" data-end=\"1001\"><strong data-start=\"823\" data-end=\"878\">P\u00e4rast edukat CTO-PCI pikaajalist prognoos on soodne<\/strong> \u2013 \u00f5igesti valitud patsientidel v\u00e4henevad stenokardia s\u00fcmptomid oluliselt ja vasaku vatsakese funktsioon paraneb.<\/p>\n<\/li>\n<\/ul>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-fe9fdee elementor-widget elementor-widget-heading\" data-id=\"fe9fdee\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\">J\u00e4reldused<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-bd0d594 elementor-widget elementor-widget-text-editor\" data-id=\"bd0d594\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p class=\"\" data-start=\"57\" data-end=\"736\"><strong data-start=\"57\" data-end=\"205\">CTO PCI protseduur kogub kiiresti populaarsust kaasaegses interventsionaalses kardioloogias<\/strong> ning muudab p\u00f5hjalikult keerukaid koronaararterite haiguse ravistrateegiaid. Kuigi ajalooliselt kasutati seda protseduuri harva \u2013 see moodustas vaid umbes 5% k\u00f5igist PCI protseduuridest maailmas<strong> [10] ja<\/strong> prooviti vaid 10\u201315% <strong>juhtudest [16][17][18]<\/strong> \u2013 viivad tehnoloogiline areng ja protseduurioperaatorite kasvav kogemus paradigmanihkeni \u2013 t\u00e4nap\u00e4eval on CTO PCI edukuse m\u00e4\u00e4r m\u00e4rkimisv\u00e4\u00e4rselt kasvanud, samas kui t\u00fcsistuste sagedus on j\u00e4rsult v\u00e4henenud. N\u00e4iteks leidsid Patel jt, et raskete t\u00fcsistuste sagedus langes 1,6%-lt (2000\u20132002) vaid 0,5%-ni (2009\u20132011) <strong> [19].<\/strong><\/p><p class=\"\" data-start=\"738\" data-end=\"1236\"><strong data-start=\"738\" data-end=\"853\">Randomiseeritud kliinilised uuringud kinnitavad CTO-PCI peamist eelist \u2013 paremat s\u00fcmptomite leevendamist.<\/strong> Lisaks v\u00f5imaldavad k\u00e4imasolevad uuendused ravida varem &#8220;ravimatuteks&#8221; peetud veresoonte kahjustusi, muutes need sobivaks revaskulariseerimisprotseduurideks <strong>[29].<\/strong> V\u00f5rreldes optimaalse raviga (OMT) pakub CTO-PCI patsientidele olulisi eeliseid: v\u00e4henenud f\u00fc\u00fcsilised piirangud, v\u00e4hem stenokardia s\u00fcmptomeid, paremat liikuvust ja suurenenud f\u00fc\u00fcsilist aktiivsust.<\/p> <p class=\"\" data-start=\"1238\" data-end=\"1622\"><strong data-start=\"1238\" data-end=\"1382\">Pildistamisvahendite, kateetritehnoloogiate ja protseduurimeetodite arenguga eeldatakse, et CTO-PCI protseduuride edukuse m\u00e4\u00e4r j\u00e4tkab kasvu. <\/strong> Arstide jaoks, kes t\u00f6\u00f6tavad CTO patsientidega, on individuaalne, patsiendikeskne l\u00e4henemine \u00e4\u00e4rmiselt oluline \u2013 kasutades uusimaid tehnoloogiaid ja kliinilisi t\u00f5endeid, et saavutada parimad tulemused ja parem elukvaliteet.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-944e0fd elementor-widget elementor-widget-heading\" data-id=\"944e0fd\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\">Juhtumiuuringud<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-2ee30af elementor-widget__width-initial elementor-widget elementor-widget-image\" data-id=\"2ee30af\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"image.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<a href=\"https:\/\/ambercell.eu\/wp-content\/uploads\/2025\/06\/Copy-of-CTO-PCI-atvejo-analize-1z.pdf\">\n\t\t\t\t\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"544\" height=\"762\" src=\"https:\/\/ambercell.eu\/wp-content\/uploads\/2025\/06\/cto-case-study-paveikslelis.jpg\" class=\"attachment-large size-large wp-image-11462\" alt=\"\" srcset=\"https:\/\/ambercell.eu\/wp-content\/uploads\/2025\/06\/cto-case-study-paveikslelis.jpg 544w, https:\/\/ambercell.eu\/wp-content\/uploads\/2025\/06\/cto-case-study-paveikslelis-214x300.jpg 214w\" sizes=\"(max-width: 544px) 100vw, 544px\" \/>\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-f6de531 elementor-widget__width-initial elementor-widget elementor-widget-image\" data-id=\"f6de531\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"image.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<a href=\"https:\/\/ambercell.eu\/wp-content\/uploads\/2025\/06\/Copy-of-CTO-Kalnins-Case-study-LT-3.pdf\">\n\t\t\t\t\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"558\" height=\"789\" src=\"https:\/\/ambercell.eu\/wp-content\/uploads\/2025\/06\/case-study-kanins.webp\" class=\"attachment-large size-large wp-image-11470\" alt=\"\" \/>\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-9d13e39 e-flex e-con-boxed e-con e-parent\" data-id=\"9d13e39\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-ac525b2 elementor-widget__width-auto elementor-widget elementor-widget-text-editor\" data-id=\"ac525b2\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p><em>Allikad: <\/em><\/p>\n<p><em><strong>[0]<\/strong> Christian O. Koelbl, Zoran S. Nedeljkovic2 ja Alice K. Jacobs, Koronaarne krooniline t\u00e4ielik oklusioon (CTO): \u00fclevaade; Columbia \u00fclikooli kardioloogia osakond Mount Sinai s\u00fcdameinstituut 4300 Alton Road De Hirsch Meyer Tower Suite 2070 Miami Beach, FL 33140, Ameerika \u00dchendriigid<\/em><br><em><strong>[1]<\/strong> Jeroudi OM, Alomar ME, Michael TT, El Sabbagh A, Patel VG, Mogabgab O jt. Koronaarsete krooniliste t\u00e4ieliku oklusioonide levimus ja ravi kolmanda taseme veteranide haiglas. Kateeter Cardiovasc Interv. 2014; 84(4):637-43.<\/em><br><em><strong>[2]<\/strong> Windecker S, Kolh P, Alfonso F, Collet JP, Cremer J, Falk V jt; Autorid\/rakker\u00fchma liikmed. 2014. aasta ESC\/EACTS suunised m\u00fcokardi revaskularisatsiooni kohta: Euroopa Kardioloogide Seltsi (ESC) ja Euroopa Kardio-Rindkerekirurgia Assotsiatsiooni (EACTS) m\u00fcokardi revaskularisatsiooni t\u00f6\u00f6r\u00fchm V\u00e4lja t\u00f6\u00f6tatud Euroopa Perkutaansete Kardiovaskulaarsete Sekkumiste Assotsiatsiooni (EAPCI) erilise panusega. Eur, Heart, J., 2014; 35(37):2541-619.<\/em><br><em><strong>[3]<\/strong> Patel MR, Calhoon JH, Dehmer GJ, Grantham JA, Maddox TM, Maron DJ jt. ACC\/AATS\/AHA\/ASE\/ASNC\/SCAI\/SCCT\/STS 2017 Stabiilse s\u00fcdame isheemiat\u00f5vega patsientide koronaarse revaskularisatsiooni asjakohased kasutuskriteeriumid: Ameerika Kardioloogiakolled\u017ei asjakohase kasutamise kriteeriumide t\u00f6\u00f6r\u00fchma, Ameerika rindkerekirurgia assotsiatsiooni, Ameerika S\u00fcdameassotsiatsiooni aruanne,  Ameerika ehhokardiograafia selts, Ameerika tuumakardioloogia selts, kardiovaskulaarse angiograafia ja sekkumiste selts, kardiovaskulaarse kompuutertomograafia selts ja rindkerekirurgide selts. J olen kadunud kardiol. 2017; 69(17):2212-41.<\/em><br><em><strong>[4]<\/strong> Werner GS, Surber R, Ferrari M, Fritzenwanger M, Figulla HR. Pikaajaliste krooniliste koronaarsete oklusioonide funktsionaalne reserv patsientidel, kellel pole eelnevat m\u00fcokardiinfarkti. Eur, S\u00fcda, J., 2006; 27(20):2406-12.<\/em><br><em><strong>[5]<\/strong> &#8211; Kirschbaum SW, Rossi A, Boersma E, Springeling T, van de Ent M, Krestin GP jt. Magnetresonantsi eluj\u00f5ulisuse muutujate kombineerimine ennustab paremini m\u00fcokardi funktsiooni paranemist enne perkutaanset koronaarset sekkumist. Sa oled J Cardiol. 2012; 159(3):192-7.<\/em><br><em><strong>[6]<\/strong> Wilson WM, Walsh SJ, Yan AT, Hanratty CG, Bagnall AJ, Egred M jt. H\u00fcbriidne l\u00e4henemine parandab kroonilise t\u00e4ieliku oklusiooni angioplastika edukust. S\u00fcda. 2016; 102(18):1486-93.<\/em><br><em><strong>[7]<\/strong> Sapontis J, Salisbury AC, Yeh RW, Cohen DJ, Hirai T, Lombardi W jt. Varajased protseduuri ja tervisliku seisundi tulemused p\u00e4rast kroonilise t\u00e4ieliku oklusiooni angioplastikat: aruanne OPEN-CTO registrist (tulemused, patsiendi tervislik seisund ja t\u00f5husus kroonilise t\u00e4ieliku oklusiooni h\u00fcbriidprotseduurides). JACC Cardiovasc Interv. 2017; 10(15):1523-34.<\/em><br><em><strong>[8]<\/strong> Christopoulos G, Karmpaliotis D, Alaswad K, Yeh RW, Jaffer FA, Wyman RM jt. H\u00fcbriidse l\u00e4henemisviisi rakendamine ja tulemused kroonilise t\u00e4ieliku oklusiooni perkutaanse koronaarse sekkumise korral kaasaegses mitmekeskuselises USA registris. Sa oled J Cardiol. 2015; 198:222-8<\/em><\/p>\n<p><em>[<strong>9]<\/strong>Nombela-Franco L, Urena M, Jerez-Valero M jt. J-kroonilise t\u00e4ieliku oklusiooni skoori valideerimine kroonilise t\u00e4ieliku oklusiooni perkutaanse koronaarse sekkumise korral s\u00f5ltumatus kaasaegses kohordis. Circ Cardiovasc Interv 2013; 6(6):635\u2013643<\/em><br><em><strong>[10]<\/strong> &#8211; Guan C, Yang W, Song L jt. \u00c4gedate protseduuriliste tulemuste seostamine pikaajaliste tulemustega p\u00e4rast CTO PCI-d. JACC Cardiovasc Interv 2021; 14(3):278\u201388.<\/em><br><em><strong>[11]<\/strong> Christakopoulos GE, Christopoulos G, Karmpaliotis D, Alaswad K, Yeh RW, Jaffer FA jt. Patsiendi liigse kiirgusega kokkupuute ennustajad kroonilise t\u00e4ieliku oklusiooni koronaarse sekkumise ajal: \u00fclevaated kaasaegsest mitmekeskuselisest registrist. Kas J Cardiol. 2017; 33(4):478-84.<\/em><br><em><strong>[12]<\/strong> Alter S, Brinkman M, Kalra S, Nazif T, Parikh M, Kirtane AJ jt. Uudne kiirgusdoosi v\u00e4hendamise fluoroskoopiline tehnoloogia h\u00f5lbustab kroonilist t\u00e4ieliku oklusiooni perkutaanseid koronaarseid sekkumisi. EuroIntervention. 2017; 13(12):e1468-e1474.<\/em><\/p>\n<p><em><strong>[13]<\/strong> Tomasello SD, Boukhris M, Jubilato S, Marza F, Garbo R, Contegiacomo G jt. Ravistrateegiad krooniliste koguoklusioonide all kannatavatel patsientidel: Itaalia krooniliste koguoklusioonide registri tulemused. Eur, Heart, J. 2015; 36(45):3189-98.<\/em><br><em><strong>[14]<\/strong> Sapontis J, Salisbury AC, Yeh RW, Cohen DJ, Hirai T, Lombardi W jt. Varajased protseduuri ja tervisliku seisundi tulemused p\u00e4rast kroonilise t\u00e4ieliku oklusiooni angioplastikat: aruanne OPEN-CTO registrist (tulemused, patsiendi tervislik seisund ja t\u00f5husus kroonilise t\u00e4ieliku oklusiooni h\u00fcbriidprotseduurides). JACC Cardiovasc Interv. 2017; 10(15):1523-34.<\/em><br><em><strong>[15]<\/strong> Gao L, Wang Y, Liu Y, Cao F, Chen Y. Krooniliste t\u00e4ieliku oklusioonide korral ravimit elueerivate stentidega eduka revaskulariseerimise pikaajalised kliinilised tulemused: s\u00fcstemaatiline \u00fclevaade ja metaanal\u00fc\u00fcs. Kateteriseerimine ja kardiovaskulaarsed sekkumised : S\u00fcdame Angiograafia ja Sekkumiste \u00dchingu ametlik teataja. 2017; 89(S1):574-81.<\/em><br><em><strong>[16]<\/strong> Cohen H.A., Williams D.O., Holmes D.R. jt. Vanuse m\u00f5ju perkutaanse transluminaalse koronaarangioplastika protseduurile ja 1-aastasele tulemusele: NHLBI d\u00fcnaamilise registri aruanne. Am Heart J. 2003; 146(3):513-519<\/em><br><em><strong>[17]<\/strong> Fefer P, Knudtson ML, Cheema AN jt. Koronaarsete krooniliste koguoklusioonide praegused perspektiivid: Kanada mitmekeskuseline krooniliste koguoklusioonide register. J olen kadunud kardiol. 2012; 59(11):991-997.<\/em><br><em><strong>[18]<\/strong> Grantham JA, Marso SP, Spertus J jt. Kroonilise t\u00e4ieliku oklusiooni angioplastika Ameerika \u00dchendriikides. JACC Cardiovasc Interv. 2009; 2(6):479-486.<\/em><br><em><strong>[19]<\/strong> Patel VG, Brayton KM, Tamayo A jt. Angiograafiline edu ja protseduurilised t\u00fcsistused patsientidel, kellele tehakse perkutaanse koronaarse kroonilise t\u00e4ieliku oklusiooni sekkumisi. 18 061 patsiendi kaalutud metaanal\u00fc\u00fcs 65 uuringust. JACC Cardiovasc Interv. 2013; 6(2).<\/em><br><em><strong>[20]<\/strong> Christopoulos G, Menon RV, Karmpaliotis D jt. &#8220;H\u00fcbriidse l\u00e4henemisviisi&#8221; rakendamine krooniliste totaalsete oklusioonide korral patsientidel, kellel on olnud eelnev koronaararterite \u0161unteerimise operatsioon kaasaegsest mitmekeskuselisest USA registrist). Am J Cardiol. 2014;<\/em><br><em><strong>[21]<\/strong> Rathore S, Matsuo H, Terashima M jt. Protseduurilised ja haiglasisesed tulemused p\u00e4rast perkutaanset koronaarset sekkumist p\u00e4rgarterite krooniliste t\u00e4ieliku oklusioonide korral 2002\u20132008. Uudsete juhttraadi tehnikate m\u00f5ju. JACC Cardiovasc Interv. 2009; 2(6):489-497.<\/em><br><em><strong>[22]<\/strong> Werner GS, Martin-Yuste V, Hildick-Smith D, Boudou N, Sianos G, Gelev V, Rumoroso JR, Erglis A, Christiansen EH, Escaned J jt; EUROCTO uuringu uurijad. Randomiseeritud mitmekeskuseline uuring, et v\u00f5rrelda revaskularisatsiooni optimaalse meditsiinilise raviga krooniliste koronaarsete oklusioonide raviks. Eur Heart J. 2018; 39:2484\u20132493. doi:10.1093\/eurheartj\/ehy220<\/em><br><em><strong>[23]<\/strong> Schumacher SP, Stuijfzand WJ, de Winter RW, van Diemen PA, Bom MJ, Everaars H jt. Isheemilise koormuse v\u00e4hendamine ja pikaajalised kliinilised tulemused p\u00e4rast kroonilist t\u00e4ieliku oklusiooni perkutaanset koronaarsekkumist. JACC Cardiovasc Interv. (2021) 14:1407\u201318. doi: 10.1016\/j.jcin.2021.04.044<\/em><br><em>[24] Zhao S, Wang J, Chen Y, Wang W, Hu W, Zou Y jt. S\u00fcmptomite ja elukvaliteedi paranemine p\u00e4rast edukat perkutaanset koronaarset sekkumist kroonilise t\u00e4ieliku oklusiooni korral eakatel patsientidel. J Am Heart Assoc. (2023) 12:e029034. doi: 10.1161\/JAHA.123.029034<\/em><br><em><strong><\/strong> Kucukseymen S, Iannaccone M, Grantham JA, Sapontis J, Juricic S, Ciardetti N jt. Krooniliste totaalsete oklusioonide eduka perkutaanse revaskularisatsiooni seos elukvaliteediga: s\u00fcstemaatiline \u00fclevaade ja metaanal\u00fc\u00fcs. Netw avatud. (2023) 6:E2324522. doi: 10.1001\/jamanetworkopen.2023.24522<\/em><br><em>[26] Megaly M, Brilakis ES, Abdelsalam M, Pershad A, Saad M, Garcia S jt. Kroonilise t\u00e4ieliku oklusiooni revaskularisatsiooni m\u00f5ju vasaku vatsakese funktsioonile, hinnatuna s\u00fcdame magnetresonantsi abil. JACC kardiovasci pildistamine. (2021) 14:1076\u20138. doi:10.1016\/j.jcmg.2020.10.012<\/em><br><em><strong>[27]<\/strong> Galassi AR, Brilakis ES, Boukhris M, Tomasello SD, Sianos G, Karmpaliotis D jt. Koronaarsete krooniliste totaalsete oklusioonide perkutaanse revaskulariseerimise asjakohasus: \u00fclevaade. S\u00fcda J. (2015) 37: 2692\u2013700. doi: 10.1093\/eurheartj\/ehv391<\/em><br><em><strong>[28]<\/strong> Watanabe H, Morimoto T, Shiomi H, Furukawa Y, Nakagawa Y, Ando K jt. Krooniline t\u00e4ielik oklusioon infarktiga mitteseotud arteris on tihedalt seotud suurenenud viieaastase suremusega ST-segmendi t\u00f5usuga \u00e4geda m\u00fcokardiinfarktiga patsientidel, kellele tehakse primaarne perkutaanne koronaarne sekkumine (CREDO-Kyoto AMI registrist). EuroIntervention. (2017) 12: e1874\u201382. doi: 10.4244\/EIJ-D-15-00421<\/em><br><em><strong>[29]<\/strong> Lindsey Cilia, Michael Megaly, Michael Megaly, Rhian Davies Rhian, Davies Behnam N. Tehrani Behnam N. Tehrani,. Truesdell, Alexander G. Truesdel; Mittesekkuva kardioloogi juhend koronaarsete krooniliste t\u00e4ieliku oklusioonide kohta; Virginia Heart, Fallsi kirik, VA, Ameerika \u00dchendriigid<\/em><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-b84e77e e-flex e-con-boxed e-con e-parent\" data-id=\"b84e77e\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t<div class=\"elementor-element elementor-element-6910637 e-flex e-con-boxed e-con e-child\" data-id=\"6910637\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t<div class=\"elementor-element elementor-element-338ce06 e-flex e-con-boxed e-con e-child\" data-id=\"338ce06\" data-element_type=\"container\" data-e-type=\"container\" data-settings=\"{&quot;background_background&quot;:&quot;classic&quot;}\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t<div class=\"elementor-element elementor-element-4148d83 e-con-full e-flex e-con e-child\" data-id=\"4148d83\" data-element_type=\"container\" data-e-type=\"container\" data-settings=\"{&quot;background_background&quot;:&quot;classic&quot;}\">\n\t\t\t\t<div class=\"elementor-element elementor-element-7f33481 elementor-widget elementor-widget-heading\" data-id=\"7f33481\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\">Tooted<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-59011ac e-con-full elementor-hidden-mobile e-flex e-con e-child\" data-id=\"59011ac\" data-element_type=\"container\" data-e-type=\"container\" data-settings=\"{&quot;background_background&quot;:&quot;classic&quot;}\">\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-51d5c8e e-flex e-con-boxed e-con e-child\" data-id=\"51d5c8e\" data-element_type=\"container\" data-e-type=\"container\" data-settings=\"{&quot;background_background&quot;:&quot;classic&quot;}\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t<div class=\"elementor-element elementor-element-37b0a47 e-flex e-con-boxed e-con e-child\" data-id=\"37b0a47\" data-element_type=\"container\" data-e-type=\"container\" data-settings=\"{&quot;background_background&quot;:&quot;classic&quot;}\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t<div class=\"elementor-element elementor-element-2a7c4cf e-flex e-con-boxed e-con e-child\" data-id=\"2a7c4cf\" data-element_type=\"container\" data-e-type=\"container\" data-settings=\"{&quot;background_background&quot;:&quot;classic&quot;}\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-e620739 elementor-position-top elementor-widget elementor-widget-image-box\" data-id=\"e620739\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"image-box.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<div class=\"elementor-image-box-wrapper\"><figure class=\"elementor-image-box-img\"><a href=\"https:\/\/www.terumo-europe.com\/en-emea\/products\/quiremspheres%E2%84%A2-microspheres\" target=\"_blank\" tabindex=\"-1\"><img decoding=\"async\" src=\"https:\/\/ambercell.eu\/wp-content\/uploads\/elementor\/thumbs\/9-1-qllqn8feypy0pkqspzwyr7037ymnhac5rr4ewqtidg.webp\" title=\"9\" alt=\"9\" loading=\"lazy\" \/><\/a><\/figure><div class=\"elementor-image-box-content\"><h3 class=\"elementor-image-box-title\"><a href=\"https:\/\/www.terumo-europe.com\/en-emea\/products\/quiremspheres%E2%84%A2-microspheres\" target=\"_blank\">QUIREMI SF\u00c4\u00c4RID<\/a><\/h3><p class=\"elementor-image-box-description\">TERUMi organiatsiooni Holmiumi platvorm on esimene SIRT: terviklik platvorm mitteopereeritavate maksakasvajate raviks. Quiremspheres\u2122: ainus SIRTi terapeutiline mikrosf\u00e4\u00e4r, mida kasutatakse t\u00e4ielikult integreeritud platvormi osana<\/p><\/div><\/div>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-b4069ba e-flex e-con-boxed e-con e-child\" data-id=\"b4069ba\" data-element_type=\"container\" data-e-type=\"container\" data-settings=\"{&quot;background_background&quot;:&quot;classic&quot;}\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-bc6ed07 elementor-position-top elementor-widget elementor-widget-image-box\" data-id=\"bc6ed07\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"image-box.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<div class=\"elementor-image-box-wrapper\"><figure class=\"elementor-image-box-img\"><a href=\"https:\/\/www.terumo-europe.com\/en-emea\/products\/occlusafe%E2%84%A2-temporary-occlusion-balloon-microcatheter\" target=\"_blank\" tabindex=\"-1\"><img decoding=\"async\" src=\"https:\/\/ambercell.eu\/wp-content\/uploads\/elementor\/thumbs\/10-qllqn2sdtpqarwyzmxh7c8fbnneg73prqz7i131ves.webp\" title=\"10\" alt=\"10\" loading=\"lazy\" \/><\/a><\/figure><div class=\"elementor-image-box-content\"><h3 class=\"elementor-image-box-title\"><a href=\"https:\/\/www.terumo-europe.com\/en-emea\/products\/occlusafe%E2%84%A2-temporary-occlusion-balloon-microcatheter\" target=\"_blank\">OCCLUSAFE<\/a><\/h3><p class=\"elementor-image-box-description\">Terumo tootja oklusiivne ballooni mikrokatater annab v\u00f5imaluse verevoolu \u00fcmber jaotada ja saavutada mikrovereringe, mis suurendab tervendavate ainete kogunemist sihtkahjustusse ja v\u00e4hendab mitte-sihtm\u00e4rgi emboliseerimist.<\/p><\/div><\/div>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-ca678f8 e-flex e-con-boxed e-con e-child\" data-id=\"ca678f8\" data-element_type=\"container\" data-e-type=\"container\" data-settings=\"{&quot;background_background&quot;:&quot;classic&quot;}\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-53cbc84 elementor-position-top elementor-widget elementor-widget-image-box\" data-id=\"53cbc84\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"image-box.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<div class=\"elementor-image-box-wrapper\"><figure class=\"elementor-image-box-img\"><a href=\"https:\/\/www.terumo-europe.com\/en-emea\/products\/progreat%E2%84%A2-micro-catheter-system\" target=\"_blank\" tabindex=\"-1\"><img decoding=\"async\" src=\"https:\/\/ambercell.eu\/wp-content\/uploads\/elementor\/thumbs\/Untitled-design-8-qllqmy36vjjv5v5tedg2hrm0oq1m4m742by2mp8u9w.webp\" title=\"Untitled design\" alt=\"Untitled design\" loading=\"lazy\" \/><\/a><\/figure><div class=\"elementor-image-box-content\"><h3 class=\"elementor-image-box-title\"><a href=\"https:\/\/www.terumo-europe.com\/en-emea\/products\/progreat%E2%84%A2-micro-catheter-system\" target=\"_blank\">PROGREAT  <\/a><\/h3><p class=\"elementor-image-box-description\">TERUMO mikrokateeter koos integreeritud traadiga terapeutiliseks emboliseerimiseks ja angiograafiaks perifeersetes veresoontes. Kasutamise lihtsus, paindumiskindlus, distaalne painduvus<\/p><\/div><\/div>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-573d9d9 e-flex e-con-boxed e-con e-child\" data-id=\"573d9d9\" data-element_type=\"container\" data-e-type=\"container\" data-settings=\"{&quot;background_background&quot;:&quot;classic&quot;}\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-027bb00 elementor-position-top elementor-widget elementor-widget-image-box\" data-id=\"027bb00\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"image-box.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<div class=\"elementor-image-box-wrapper\"><figure class=\"elementor-image-box-img\"><a href=\"https:\/\/www.terumo-europe.com\/en-emea\/products\/angio-seal%E2%84%A2-vip-vascular-closure-device\" target=\"_blank\" tabindex=\"-1\"><img decoding=\"async\" src=\"https:\/\/ambercell.eu\/wp-content\/uploads\/elementor\/thumbs\/Untitled-design-1-6-qllqmubu47epvfba0btk7sk6b6k59ts6ptc4pleeys.webp\" title=\"Untitled design (1)\" alt=\"Untitled design (1)\" loading=\"lazy\" \/><\/a><\/figure><div class=\"elementor-image-box-content\"><h3 class=\"elementor-image-box-title\"><a href=\"https:\/\/www.terumo-europe.com\/en-emea\/products\/angio-seal%E2%84%A2-vip-vascular-closure-device\" target=\"_blank\">ANGIO SEAL VIP<\/a><\/h3><p class=\"elementor-image-box-description\">Angio-Seal\u2122 VIP Cruciate Vein Closure Device sulgemiseks ja hemostaasini kuluva aja l\u00fchendamiseks \u00fchise reieluukaarepunktsiooni kohas patsientidel, kes l\u00e4bivad diagnostilist angiograafiat v\u00f5i sekkumisprotseduuri.<\/p><\/div><\/div>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-a97adac elementor-widget-divider--view-line elementor-widget elementor-widget-divider\" data-id=\"a97adac\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"divider.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<div class=\"elementor-divider\">\n\t\t\t<span class=\"elementor-divider-separator\">\n\t\t\t\t\t\t<\/span>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-c4c2f91 elementor-widget elementor-widget-button\" data-id=\"c4c2f91\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"button.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<div class=\"elementor-button-wrapper\">\n\t\t\t\t\t<a class=\"elementor-button elementor-button-link elementor-size-sm\" href=\"https:\/\/ambercell.eu\/et\/tooted\/\">\n\t\t\t\t\t\t<span class=\"elementor-button-content-wrapper\">\n\t\t\t\t\t\t<span class=\"elementor-button-icon\">\n\t\t\t\t<svg aria-hidden=\"true\" class=\"e-font-icon-svg e-fas-long-arrow-alt-right\" viewBox=\"0 0 448 512\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path d=\"M313.941 216H12c-6.627 0-12 5.373-12 12v56c0 6.627 5.373 12 12 12h301.941v46.059c0 21.382 25.851 32.09 40.971 16.971l86.059-86.059c9.373-9.373 9.373-24.569 0-33.941l-86.059-86.059c-15.119-15.119-40.971-4.411-40.971 16.971V216z\"><\/path><\/svg>\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t<span class=\"elementor-button-text\">K\u00f5ik tooted<\/span>\n\t\t\t\t\t<\/span>\n\t\t\t\t\t<\/a>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-872ea83 e-flex e-con-boxed e-con e-parent\" data-id=\"872ea83\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"<p>Perkutaanne koronaarinterventsioon (PCI) on minimaalselt invasiivne koronaararterite protseduur, mis on m\u00f5eldud ahenenud v\u00f5i ummistunud koronaararterite avamiseks, mis varustavad s\u00fcdant verega. Seda tehakse k\u00f5ige sagedamini isheemilise s\u00fcdamehaigusega patsientidel v\u00f5i neil, kellel on olnud m\u00fcokardiinfarkt.<\/p>\n","protected":false},"author":5,"featured_media":10625,"parent":4692,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-10418","page","type-page","status-publish","has-post-thumbnail","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Selektiivne liigesesisene kiiritusravi | AmberCell<\/title>\n<meta name=\"description\" content=\"Innovatiivne selektiivne arterisisene kiiritusravi HCC ja mCRC kasvajate raviks. Radioemboolia, SIRT-protseduurid maksav\u00e4hi diagnostilisteks ja ravietappideks.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ambercell.eu\/et\/arstide-jaoks\/sudame-veresoonkonna-haigused\/selektiivne-arterisisene-kiiritusravi-sirt-2\/\" \/>\n<meta property=\"og:locale\" content=\"et_EE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Selektiivne liigesesisene kiiritusravi | AmberCell\" \/>\n<meta property=\"og:description\" content=\"Innovatiivne selektiivne arterisisene kiiritusravi HCC ja mCRC kasvajate raviks. Radioemboolia, SIRT-protseduurid maksav\u00e4hi diagnostilisteks ja ravietappideks.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ambercell.eu\/et\/arstide-jaoks\/sudame-veresoonkonna-haigused\/selektiivne-arterisisene-kiiritusravi-sirt-2\/\" \/>\n<meta property=\"og:site_name\" content=\"Ambercell\" \/>\n<meta property=\"article:modified_time\" content=\"2026-11-12T11:35:59+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ambercell.eu\/wp-content\/uploads\/2025\/04\/whUL0SDKS9kDVHxJQGo32LLl1A0NyVOWgYFf6VrN.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1004\" \/>\n\t<meta property=\"og:image:height\" content=\"795\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Eeldatav lugemisaeg\" \/>\n\t<meta name=\"twitter:data1\" content=\"13 minutit\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/ambercell.eu\\\/et\\\/arstide-jaoks\\\/sudame-veresoonkonna-haigused\\\/selektiivne-arterisisene-kiiritusravi-sirt-2\\\/\",\"url\":\"https:\\\/\\\/ambercell.eu\\\/et\\\/arstide-jaoks\\\/sudame-veresoonkonna-haigused\\\/selektiivne-arterisisene-kiiritusravi-sirt-2\\\/\",\"name\":\"Selektiivne liigesesisene kiiritusravi | AmberCell\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ambercell.eu\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/ambercell.eu\\\/et\\\/arstide-jaoks\\\/sudame-veresoonkonna-haigused\\\/selektiivne-arterisisene-kiiritusravi-sirt-2\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/ambercell.eu\\\/et\\\/arstide-jaoks\\\/sudame-veresoonkonna-haigused\\\/selektiivne-arterisisene-kiiritusravi-sirt-2\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/ambercell.eu\\\/wp-content\\\/uploads\\\/2025\\\/04\\\/whUL0SDKS9kDVHxJQGo32LLl1A0NyVOWgYFf6VrN.webp\",\"datePublished\":\"2025-04-09T07:19:58+00:00\",\"dateModified\":\"2026-11-12T11:35:59+00:00\",\"description\":\"Innovatiivne selektiivne arterisisene kiiritusravi HCC ja mCRC kasvajate raviks. Radioemboolia, SIRT-protseduurid maksav\u00e4hi diagnostilisteks ja ravietappideks.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/ambercell.eu\\\/et\\\/arstide-jaoks\\\/sudame-veresoonkonna-haigused\\\/selektiivne-arterisisene-kiiritusravi-sirt-2\\\/#breadcrumb\"},\"inLanguage\":\"et\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/ambercell.eu\\\/et\\\/arstide-jaoks\\\/sudame-veresoonkonna-haigused\\\/selektiivne-arterisisene-kiiritusravi-sirt-2\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"et\",\"@id\":\"https:\\\/\\\/ambercell.eu\\\/et\\\/arstide-jaoks\\\/sudame-veresoonkonna-haigused\\\/selektiivne-arterisisene-kiiritusravi-sirt-2\\\/#primaryimage\",\"url\":\"https:\\\/\\\/ambercell.eu\\\/wp-content\\\/uploads\\\/2025\\\/04\\\/whUL0SDKS9kDVHxJQGo32LLl1A0NyVOWgYFf6VrN.webp\",\"contentUrl\":\"https:\\\/\\\/ambercell.eu\\\/wp-content\\\/uploads\\\/2025\\\/04\\\/whUL0SDKS9kDVHxJQGo32LLl1A0NyVOWgYFf6VrN.webp\",\"width\":1004,\"height\":795},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/ambercell.eu\\\/et\\\/arstide-jaoks\\\/sudame-veresoonkonna-haigused\\\/selektiivne-arterisisene-kiiritusravi-sirt-2\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/ambercell.eu\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Arstide jaoks\",\"item\":\"https:\\\/\\\/ambercell.eu\\\/et\\\/arstide-jaoks\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"S\u00fcdame-veresoonkonna haigused\",\"item\":\"https:\\\/\\\/ambercell.eu\\\/et\\\/arstide-jaoks\\\/sudame-veresoonkonna-haigused\\\/\"},{\"@type\":\"ListItem\",\"position\":4,\"name\":\"Perkutaanne koronaarne sekkumine (CTO PCI)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/ambercell.eu\\\/#website\",\"url\":\"https:\\\/\\\/ambercell.eu\\\/\",\"name\":\"Ambercell\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/ambercell.eu\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/ambercell.eu\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"et\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/ambercell.eu\\\/#organization\",\"name\":\"Ambercell\",\"url\":\"https:\\\/\\\/ambercell.eu\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"et\",\"@id\":\"https:\\\/\\\/ambercell.eu\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/ambercell.eu\\\/wp-content\\\/uploads\\\/2023\\\/11\\\/Ambercell-LOGO-@2x.webp\",\"contentUrl\":\"https:\\\/\\\/ambercell.eu\\\/wp-content\\\/uploads\\\/2023\\\/11\\\/Ambercell-LOGO-@2x.webp\",\"width\":438,\"height\":164,\"caption\":\"Ambercell\"},\"image\":{\"@id\":\"https:\\\/\\\/ambercell.eu\\\/#\\\/schema\\\/logo\\\/image\\\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Selektiivne liigesesisene kiiritusravi | AmberCell","description":"Innovatiivne selektiivne arterisisene kiiritusravi HCC ja mCRC kasvajate raviks. Radioemboolia, SIRT-protseduurid maksav\u00e4hi diagnostilisteks ja ravietappideks.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ambercell.eu\/et\/arstide-jaoks\/sudame-veresoonkonna-haigused\/selektiivne-arterisisene-kiiritusravi-sirt-2\/","og_locale":"et_EE","og_type":"article","og_title":"Selektiivne liigesesisene kiiritusravi | AmberCell","og_description":"Innovatiivne selektiivne arterisisene kiiritusravi HCC ja mCRC kasvajate raviks. Radioemboolia, SIRT-protseduurid maksav\u00e4hi diagnostilisteks ja ravietappideks.","og_url":"https:\/\/ambercell.eu\/et\/arstide-jaoks\/sudame-veresoonkonna-haigused\/selektiivne-arterisisene-kiiritusravi-sirt-2\/","og_site_name":"Ambercell","article_modified_time":"2026-11-12T11:35:59+00:00","og_image":[{"width":1004,"height":795,"url":"https:\/\/ambercell.eu\/wp-content\/uploads\/2025\/04\/whUL0SDKS9kDVHxJQGo32LLl1A0NyVOWgYFf6VrN.webp","type":"image\/webp"}],"twitter_card":"summary_large_image","twitter_misc":{"Eeldatav lugemisaeg":"13 minutit"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/ambercell.eu\/et\/arstide-jaoks\/sudame-veresoonkonna-haigused\/selektiivne-arterisisene-kiiritusravi-sirt-2\/","url":"https:\/\/ambercell.eu\/et\/arstide-jaoks\/sudame-veresoonkonna-haigused\/selektiivne-arterisisene-kiiritusravi-sirt-2\/","name":"Selektiivne liigesesisene kiiritusravi | AmberCell","isPartOf":{"@id":"https:\/\/ambercell.eu\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ambercell.eu\/et\/arstide-jaoks\/sudame-veresoonkonna-haigused\/selektiivne-arterisisene-kiiritusravi-sirt-2\/#primaryimage"},"image":{"@id":"https:\/\/ambercell.eu\/et\/arstide-jaoks\/sudame-veresoonkonna-haigused\/selektiivne-arterisisene-kiiritusravi-sirt-2\/#primaryimage"},"thumbnailUrl":"https:\/\/ambercell.eu\/wp-content\/uploads\/2025\/04\/whUL0SDKS9kDVHxJQGo32LLl1A0NyVOWgYFf6VrN.webp","datePublished":"2025-04-09T07:19:58+00:00","dateModified":"2026-11-12T11:35:59+00:00","description":"Innovatiivne selektiivne arterisisene kiiritusravi HCC ja mCRC kasvajate raviks. Radioemboolia, SIRT-protseduurid maksav\u00e4hi diagnostilisteks ja ravietappideks.","breadcrumb":{"@id":"https:\/\/ambercell.eu\/et\/arstide-jaoks\/sudame-veresoonkonna-haigused\/selektiivne-arterisisene-kiiritusravi-sirt-2\/#breadcrumb"},"inLanguage":"et","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ambercell.eu\/et\/arstide-jaoks\/sudame-veresoonkonna-haigused\/selektiivne-arterisisene-kiiritusravi-sirt-2\/"]}]},{"@type":"ImageObject","inLanguage":"et","@id":"https:\/\/ambercell.eu\/et\/arstide-jaoks\/sudame-veresoonkonna-haigused\/selektiivne-arterisisene-kiiritusravi-sirt-2\/#primaryimage","url":"https:\/\/ambercell.eu\/wp-content\/uploads\/2025\/04\/whUL0SDKS9kDVHxJQGo32LLl1A0NyVOWgYFf6VrN.webp","contentUrl":"https:\/\/ambercell.eu\/wp-content\/uploads\/2025\/04\/whUL0SDKS9kDVHxJQGo32LLl1A0NyVOWgYFf6VrN.webp","width":1004,"height":795},{"@type":"BreadcrumbList","@id":"https:\/\/ambercell.eu\/et\/arstide-jaoks\/sudame-veresoonkonna-haigused\/selektiivne-arterisisene-kiiritusravi-sirt-2\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ambercell.eu\/"},{"@type":"ListItem","position":2,"name":"Arstide jaoks","item":"https:\/\/ambercell.eu\/et\/arstide-jaoks\/"},{"@type":"ListItem","position":3,"name":"S\u00fcdame-veresoonkonna haigused","item":"https:\/\/ambercell.eu\/et\/arstide-jaoks\/sudame-veresoonkonna-haigused\/"},{"@type":"ListItem","position":4,"name":"Perkutaanne koronaarne sekkumine (CTO PCI)"}]},{"@type":"WebSite","@id":"https:\/\/ambercell.eu\/#website","url":"https:\/\/ambercell.eu\/","name":"Ambercell","description":"","publisher":{"@id":"https:\/\/ambercell.eu\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ambercell.eu\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"et"},{"@type":"Organization","@id":"https:\/\/ambercell.eu\/#organization","name":"Ambercell","url":"https:\/\/ambercell.eu\/","logo":{"@type":"ImageObject","inLanguage":"et","@id":"https:\/\/ambercell.eu\/#\/schema\/logo\/image\/","url":"https:\/\/ambercell.eu\/wp-content\/uploads\/2023\/11\/Ambercell-LOGO-@2x.webp","contentUrl":"https:\/\/ambercell.eu\/wp-content\/uploads\/2023\/11\/Ambercell-LOGO-@2x.webp","width":438,"height":164,"caption":"Ambercell"},"image":{"@id":"https:\/\/ambercell.eu\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/ambercell.eu\/et\/wp-json\/wp\/v2\/pages\/10418","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ambercell.eu\/et\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/ambercell.eu\/et\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/ambercell.eu\/et\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/ambercell.eu\/et\/wp-json\/wp\/v2\/comments?post=10418"}],"version-history":[{"count":4,"href":"https:\/\/ambercell.eu\/et\/wp-json\/wp\/v2\/pages\/10418\/revisions"}],"predecessor-version":[{"id":12570,"href":"https:\/\/ambercell.eu\/et\/wp-json\/wp\/v2\/pages\/10418\/revisions\/12570"}],"up":[{"embeddable":true,"href":"https:\/\/ambercell.eu\/et\/wp-json\/wp\/v2\/pages\/4692"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ambercell.eu\/et\/wp-json\/wp\/v2\/media\/10625"}],"wp:attachment":[{"href":"https:\/\/ambercell.eu\/et\/wp-json\/wp\/v2\/media?parent=10418"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}